3) Let's look at the main results of their model. It estimates that LC cases peaked in 2022 and decreased to a steadier number of around 800,000 thereafter.
ME/CFS prevalence rose from 400.000 in 2019 to more than 600,000 cases in 2024, so an increase of around 50%.